.png)
Newborn Screening Market By Product, Technology And Test- Global Industry Analysis And Forecast To 2023
Published On : May 2022 Pages : 100 Category: Biotechnology Report Code : HC05766
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
The Newborn Screening Market was worth USD billion in 2017 and is expected to reach approximately USD billion by 2023, while registering itself at a compound annual growth rate (CAGR) of % during the forecast period. Developing neonatal populace base, rising instances of congenital diseases in newborns, ideal government programs and enactments, and technological progressions are foreseen to fill in as imperative drivers of the newborn screening market. Rising neonatal populace is one of the key market drivers. To avert this efforts are being taken by associations, for example, the WHO, CDC, Healthy Newborn Network, and so on, to instruct parents for the possible disorders and their indicative procedures. In expansion, government projects and enactments likewise make a positive domain to cultivate market development.
Product Outlook and Trend Analysis
Instruments used for newborn screening incorporate pulse oximeters, mass spectrometers, fractionators, and others. The instruments market segment is foreseen to encounter development inferable from expanding interest for infant screening over the globe.
Technology Outlook and Trend Analysis
Tandem mass spectrometry (TMS) is a progressed logical instrument used as a part of the research facilities which can examine body liquids and other body contaminants. Tandem mass spectrometry ruled the general market in 2017 inferable from appeal because of cost adequacy, higher applicability and technological up gradation. Tandem spectroscopy (MS/MS) is foreseen to develop at a tremendous CAGR over the figure time frame, because of its high capacity in diagnosing a variety of conditions in a single procedure.
Test Type Outlook and Trend Analysis
Dry blood spot tests ruled the general newborn screening market representing more than % of income. The collection of blood from newborn’s heel area in 24-48 hours of birth on the screening card for analysis of more than 50 conditions is named as heel stick or dried blood spot test (DBS). These screening cards are labeled using different codes and contain no extra identity data. Critical Congenital Heart Disease (CCHD) is one of the normally happening issues, which is screened using the beat oximeter based technology.
Regional Outlook and Trend Analysis
North America held the biggest share of the newborn screening market inferable from the developing predominance of congenital disorders and implemented testing in all the 50 conditions of the country. Newborn screening program is diligently followed in every one of the conditions of North America. Asia Pacific is foreseen to witness lucrative development over the conjecture time frame because of, the existence of good medicinal services plans drafted by government organizations.
Competitive Insights
The leading players in the market are Natus Medical Incorporated, Masimo, PerkinElmer, Covidien Ltd, Waters Corporation, Trivitron Healthcare, Bio-Rad Laboratories, Wipro GE Healthcare Pvt Ltd and Applied Biosystems/MDS Sciex J.V. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Newborn Screening Market is segmented as follows-
By Product:
- Reagents
- Instruments
By Technology:
- Pulse oximetry
- DNA assay
- Tandem mass spectrometry
- Enzyme based assay
- Electrophoresis
- Others
By Test Type:
- CCHD
- Dry blood spot test
- Hearing screen
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Newborn Screening Market, By Product, Estimates and Forecast, 2014-2023($Billion)
o Instruments
o Reagents & Assay Kits
· Newborn Screening Market, By Technology, Estimates and Forecast, 2014-2023($Billion)
o Tandem Mass Spectrometry
o Pulse Oximetry
o Enzyme Based Assays
o DNA Assays
o Electrophoresis
· Newborn Screening Market, By Test, Estimates and Forecast, 2014-2023($Billion)
o Dry Blood Spot Test
o Critical Congenital Heart Disease (CCHD)
o Hearing Screen
· Newborn Screening Market, By Region, Estimates and Forecast, 2014-2023($Billion)
o North America
§ North America Newborn Screening Market, By Country
o U.S. Newborn Screening Market
o Canada Newborn Screening Market
o Mexico Newborn Screening Market
o Europe
§ Europe Newborn Screening Market, By Country
o Germany Newborn Screening Market
o UK Newborn Screening Market
o France Newborn Screening Market
o Russia Newborn Screening Market
o Italy Newborn Screening Market
o Rest of Europe Newborn Screening Market
o Asia-Pacific
§ Asia-Pacific Newborn Screening Market, By Country
o China Newborn Screening Market
o Japan Newborn Screening Market
o South Korea Newborn Screening Market
o India Newborn Screening Market
o Southeast Asia Newborn Screening Market
o Rest of Asia-Pacific Newborn Screening Market
o South America
§ South America Newborn Screening Market
o Brazil Newborn Screening Market
o Argentina Newborn Screening Market
o Columbia Newborn Screening Market
o South Africa Newborn Screening Market
o Rest of South America Newborn Screening Market
o Middle East and Africa
§ Middle East and Africa Newborn Screening Market
o Saudi Arabia Newborn Screening Market
o UAE Newborn Screening Market
o Egypt Newborn Screening Market
o Nigeria Newborn Screening Market
o South Africa Newborn Screening Market
o Rest of MEA Newborn Screening Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Countries to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Newborn Screening Market, By Product
5.1. Introduction
5.2. Global Newborn Screening Sales, Revenue and Market Share by Product (2017-2017)
5.2.1. Global Newborn Screening Sales and Sales Share by Product (2017-2017)
5.2.2. Global Newborn Screening Revenue and Revenue Share by Product (2017-2017)
5.3. Newborn Screening Market Assessment and Forecast, By Product, 2017-2023
5.4. Instruments
5.4.1. Global Instruments Sales and Growth Rate (2017-2027)
5.5. Reagents & Assay Kits
5.5.1. Global Reagents & Assay Kits Sales and Growth Rate (2017-2027)
6. Newborn Screening Market, By Technology
6.1. Introduction
6.2. Global Newborn Screening Sales, Revenue and Market Share by Technology (2017-2017)
6.2.1. Global Newborn Screening Sales and Sales Share by Technology (2017-2017)
6.2.2. Global Newborn Screening Revenue and Revenue Share by Technology (2017-2017)
6.3. Newborn Screening Market Assessment and Forecast, By Technology, 2017-2023
6.4. Tandem Mass Spectrometry
6.4.1. Global Tandem Mass Spectrometry Sales and Growth Rate (2017-2027)
6.5. Pulse Oximetry
6.5.1. Global Pulse Oximetry Sales and Growth Rate (2017-2027)
6.6. Enzyme Based Assays
6.6.1. Global Enzyme Based Assays Sales and Growth Rate (2017-2027)
6.7. DNA Assays
6.7.1. Global DNA Assays Sales and Growth Rate (2017-2027)
6.8. Electrophoresis
6.8.1. Global Electrophoresis Sales and Growth Rate (2017-2027)
7. Newborn Screening Market, By Test
7.1. Introduction
7.2. Global Newborn Screening Sales, Revenue and Market Share by Test (2017-2017)
7.2.1. Global Newborn Screening Sales and Sales Share by Test (2017-2017)
7.2.2. Global Newborn Screening Revenue and Revenue Share by Test (2017-2017)
7.3. Newborn Screening Market Assessment and Forecast, By Test, 2017-2023($Billion)
7.4. Dry Blood Spot Test
7.4.1. Global Dry Blood Spot Test Sales and Growth Rate (2017-2027)
7.5. Critical Congenital Heart Disease (CCHD)
7.5.1. Global Critical Congenital Heart Disease (CCHD) Sales and Growth Rate (2017-2027)
7.6. Hearing Screen
7.6.1. Global Hearing Screen Sales and Growth Rate (2017-2027)
8. Newborn Screening Market, By Region
8.1. Introduction
8.2. Global Newborn Screening Sales, Revenue and Market Share by Regions
8.2.1. Global Newborn Screening Sales by Regions (2017-2027)
8.2.2. Global Newborn Screening Revenue by Regions (2017-2027)
8.3. North America Newborn Screening by Countries
8.3.1. North America Newborn Screening Sales and Growth Rate (2017-2027)
8.3.2. North America Newborn Screening Revenue and Growth Rate (2017-2027)
8.3.3. North America Newborn Screening Sales by Countries (2017-2027)
8.3.4. North America Newborn Screening Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Newborn Screening Sales and Growth Rate (2017-2027)
8.3.5.2. United States Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Newborn Screening Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Newborn Screening Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Newborn Screening Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Newborn Screening by Countries
8.4.1. Europe Newborn Screening Sales and Growth Rate (2017-2027)
8.4.2. Europe Newborn Screening Revenue and Growth Rate (2017-2027)
8.4.3. Europe Newborn Screening Sales by Countries (2017-2027)
8.4.4. Europe Newborn Screening Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Newborn Screening Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Newborn Screening Sales and Growth Rate (2017-2027)
8.4.6.2. UK Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Newborn Screening Sales and Growth Rate (2017-2027)
8.4.7.2. France Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Newborn Screening Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Newborn Screening Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Newborn Screening Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Newborn Screening Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Newborn Screening Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Newborn Screening Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Newborn Screening Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Newborn Screening Sales and Growth Rate (2017-2027)
8.5.5.2. China Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Newborn Screening Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6.3.
8.5.7. Korea
8.5.7.1. Korea Newborn Screening Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Newborn Screening Sales and Growth Rate (2017-2027)
8.5.8.2. India Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Newborn Screening Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Newborn Screening Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Newborn Screening Sales and Growth Rate (2017-2027)
8.6.2. South America Newborn Screening Revenue and Growth Rate (2017-2027)
8.6.3. South America Newborn Screening Sales by Countries (2017-2027)
8.6.4. South America Newborn Screening Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Newborn Screening Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Newborn Screening Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Newborn Screening Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Newborn Screening Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Newborn Screening Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Newborn Screening Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Newborn Screening Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Newborn Screening Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Newborn Screening Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Newborn Screening Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Newborn Screening Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Newborn Screening Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Newborn Screening Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Newborn Screening Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Newborn Screening Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Covidien Plc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Newborn Screening Sales, Revenue and Market Share
9.2. AB SCIEX
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Newborn Screening Sales, Revenue and Market Share
9.3. Bio Rad Laboratories
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Newborn Screening Sales, Revenue and Market Share
9.4. Agilent Technologies
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Newborn Screening Sales, Revenue and Market Share
9.5. Masimo Corporation
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Newborn Screening Sales, Revenue and Market Share
9.6. Waters Corporation
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Newborn Screening Sales, Revenue and Market Share
9.7. Natus Medical
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Newborn Screening Sales, Revenue and Market Share
9.8. Trivitron Healthcare
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Newborn Screening Sales, Revenue and Market Share
9.9. GE Lifesciences
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Newborn Screening Sales, Revenue and Market Share
9.10. PerkinElmer Inc
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3. Strategic Developments
9.10.4. Newborn Screening Sales, Revenue and Market Share
10. Global Newborn Screening Market Competition, by Manufacturer
10.1. Global Newborn Screening Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Newborn Screening Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Newborn Screening Price by Manufacturer (2017-2017)
10.4. Top 5 Newborn Screening Manufacturer Market Share
10.5. Market Competition Trend
11. Newborn Screening Market Forecast (2027-2023)
11.1. Global Newborn Screening Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Newborn Screening Market Forecast by Regions (2027-2023)
11.2.1. North America Newborn Screening Market Forecast (2027-2023)
11.2.1.1. United States Newborn Screening Market Forecast (2027-2023)
11.2.1.2. Canada Newborn Screening Market Forecast (2027-2023)
11.2.1.3. Mexico Newborn Screening Market Forecast (2027-2023)
11.2.2. Europe Newborn Screening Market Forecast (2027-2023)
11.2.2.1. Germany Newborn Screening Market Forecast (2027-2023)
11.2.2.2. United Kingdom Newborn Screenings Market Forecast (2027-2023)
11.2.2.3. France Newborn Screening Market Forecast (2027-2023)
11.2.2.4. Russia Newborn Screening Market Forecast (2027-2023)
11.2.2.5. Italy Newborn Screening Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Newborn Screening Market Forecast (2027-2023)
11.2.3. Asia-Pacific Newborn Screening Market Forecast (2027-2023)
11.2.3.1. China Newborn Screening Market Forecast (2027-2023)
11.2.3.2. Japan Newborn Screening Market Forecast (2027-2023)
11.2.3.3. Korea Newborn Screening Market Forecast (2027-2023)
11.2.3.4. India Newborn Screening Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Newborn Screening Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Newborn Screening Market Forecast (2027-2023)
11.2.4. South America Newborn Screening Market Forecast (2027-2023)
11.2.4.1. Brazil Newborn Screening Market Forecast (2027-2023)
11.2.4.2. Argentina Newborn Screening Market Forecast (2027-2023)
11.2.4.3. Columbia Newborn Screening Market Forecast (2027-2023)
11.2.4.4. Rest of South America Newborn Screening Market Forecast (2027-2023)
11.2.5. Middle East and Africa Newborn Screening Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Newborn Screening Market Forecast (2027-2023)
11.2.5.2. UAE Newborn Screening Market Forecast (2027-2023)
11.2.5.3. Egypt Newborn Screening Market Forecast (2027-2023)
11.2.5.4. Nigeria Newborn Screening Market Forecast (2027-2023)
11.2.5.5. South Africa Newborn Screening Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Newborn Screening Market Forecast (2027-2023)
11.3. Newborn Screening Market Forecast by Application (2027-2023)
11.3.1. Global Newborn Screening Sales Forecast by Application (2027-2023)
11.3.2. Global Newborn Screening Sales Market Share Forecast by Application (2027-2023)
11.4. Newborn Screening Market Forecast by Technology (2027-2023)
11.4.1. Global Newborn Screening Sales Forecast by Technology (2027-2023)
11.4.2. Global Newborn Screening Sales Market Share Forecast by Technology (2027-2023)
11.5. Newborn Screening Market Forecast by Test (2027-2023)
11.5.1. Global Newborn Screening Sales Forecast by Test (2027-2023)
11.5.2. Global Newborn Screening Sales Market Share Forecast by Test (2027-2023)
List of Tables and Figures
You can glance through the list of Tables and Figures when you view the sample copy of Newborn Screening Market.
List of Tables
You can glance through the list of Tables and Figures when you view the sample copy of Newborn Screening Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|